Abstract:Netherton syndrome (NS) is a rare autosomal recessive skin disease with severe skin inflammation and scaling, a specific hair shaft defect and constant allergic manifestations. NS is caused by loss-of-function mutations in SPINK5 (serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5) expressed in stratified epithelia. In vitro and in vivo studies in murine models and in NS patients have cast light on the pathogenesis of the disease and shown that LEKTI deficiency results in unopposed kallikrein-related peptidase 5 (KLK5) and KLK7 activities and to the overactivity of a new epidermal protease, elastase 2 (ELA2). Two main cascades initiated by KLK5 activity have emerged. One results in desmoglein 1 degradation and desmosome cleavage leading to stratum corneum detachment. KLK5 also activates KLK7 and ELA2, which contribute to a defective skin barrier. This facilitates allergen and microbe penetration and generates danger signals leading to caspase 1 activation and the production of active interleukin-1β. In parallel, KLK5 activates a specific cascade of allergy and inflammation by activating protease-activated receptor-2 (PAR-2) receptors. PAR-2 activation triggers the production of the major pro-Th2 cytokine TSLP (thymic stromal lymphopoietin) and several inflammatory cytokines, including tumour necrosis factor-α. Levels of thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) also contribute to allergy in a PAR-2-independent manner. Patient investigations have confirmed these abnormalities and revealed a wide spectrum of disease expression, sometimes associated with residual LEKTI expression. These results have demonstrated that the tight regulation of epidermal protease activity is essential for skin homeostasis and identified new targets for therapeutic intervention. They also provide a link with atopic dermatitis through deregulated protease activity, as recently supported by functional studies of the E420K LEKTI variant.

Detection of KLKs and Serpins in the Epidermis of Netherton Syndrome and Pemphigus Erythematosus

KRT9 Gene Mutation As a Reliable Indicator in the Prenatal Molecular Diagnosis of Epidermolytic Palmoplantar Keratoderma.

A Novel Mutation Within the 2B Rod Domain of Keratin 9 in a Chinese Pedigree with Epidermolytic Palmoplantar Keratoderma Combined with Knuckle Pads and Camptodactyly

A Study of the Abnormalities of Human Epiderm in Keloids and Hypertrophic Scars

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases

Netherton syndrome: skin inflammation and allergy by loss of protease inhibition

[Pathological Features and Gene Mutation Analysis in Two Pedigrees of Diffuse Palmoplantar Keratoderma].

Mutation Analysis of Keratin 9 Gene in a Pedigree with Epidermolytic Palmoplantar Keratoderma

Immunolocalization and Expression of Vascular Endothelial Growth Factor Receptors (VEGFRs) and Neuropilins (NRPs) on Keratinocytes in Human Epidermis

Spink5 Gene Mutation And Decreased Lekti Activity In Three Chinese Patients With Netherton'S Syndrome

Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome

Netherton Syndrome and SPINK5

Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways

Altered distribution of keratinization markers in epidermolytic hyperkeratosis

Keratin expression in discoid lupus erythematosus

Expression of Keratin 17 in Proliferative Skin Diseases

Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization

Nonsense mutations in KRT1 caused recessive epidermolytic palmoplantar keratoderma with knuckle pads

KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors

Immunohistochemical evaluation of keratins and involucrin in differentiating between palmoplantar pustulosis and pompholyx